MMP2 and cancer: Furthermore, both Metformin and Ara-a had an inhibitory effect on the invasive ability of both glial and neuronal cancer cells, possibly through decreasing MMP-2 production that is known to have a role in cancer progression by aiding extracellular matrix degradation.